UKCPA Autumn Symposium Progress in Practice Programme Overview

UKCPA Autumn Symposium
Progress in Practice
Programme Overview
Crowne Plaza, Nottingham
Friday 21st - Saturday 22nd November 2014
The UKCPA promotes expert practice in medicines management for the benefit of patients, the public and
members by establishing standards, workforce development and advancing innovation in all health care settings
The UKCPA encourages Excellence, Leadership and Partnership
Sponsored by:
Endorsed by:
Programme - UKCPA Autumn Symposium 2014
Friday 21st November
09.00
09.45
09.55
10.10
10.40
12.10
12.15
14.10
Registration desk opens, arrival refreshments served
Convene in plenary suite for commencement of symposium
Chair’s Introduction and Symposium Opening
Keynote Lecture: Making Change Work: Improvement Science
Demystified
Dr Clare Crowley, Consultant Pharmacist – Medicines Safety, Oxford
University Hospitals NHS Trust
Oral Communications
Lunch and official opening of the Medical Exhibition
First Time Attendees Welcome Meeting
Work session 1 (5 x concurrent sessions)
a) Faculty Portfolio Building Surgery: Give your portfolio a health
check! (suitable for all levels)
Helen Middleton MSc (Education), MRPharmS, FFRPS, joint Chair of
the UKCPA Education & Training Group and Professional
Development Manager at London Pharmacy Education and Training,
plus RPS Faculty Members and Fellows
If you answer “Yes” to any of these questions, this interactive
workshop is for you!
 Are you seeking professional recognition by the RPS Faculty?
 Started your portfolio and looking for support and feedback from
those who have been through the process?
 Suffering from mapping madness?
 Want to know if you are on the right track?
 Would your portfolio benefit from a health check?
This workshop will give you the opportunity to discuss your own
portfolio with the Faculty Development Leads, Faculty Members and
Fellows and your peers. Delegates will be expected to bring their
portfolio transcript, a portfolio entry and/or ideas for evidence in
relation to the Advanced Pharmacy Framework for discussion at the
workshop. The workshop will be tailored to individual needs and
there will be opportunities for one to one and small group support.
b) Consultation skills for challenging patients – substance misuse
and alcohol (I/II)
David Gibson, UKCPA General Committee Member and Lead Clinical
Pharmacist, Darlington Memorial Hospital, County Durham
The aim of this session is to share good practice about how to
approach a consultation. The focus will be on those challenging
patient groups where it is often difficult to get engagement about
their medication.
Learning outcomes: At the end of this session participants will be
able to:
 Review different consultation models and how pharmacists apply
them in everyday practice
 Consider the challenges associated with patients who misuse
substances or alcohol
 Share good practice about how we adapt our consultation style
to best meet the needs of these patients
c) New inhaled drugs for asthma and COPD: integration into UK
Asthma and COPD guideline management (II)
Toby Capstick, joint Chair of the UKCPA Respiratory Group and Lead
Respiratory Pharmacist, Leeds Teaching Hospitals NHS Trust and
Hasanin Khachi, joint Chair of the UKCPA Respiratory Group & Highly
Specialist Pharmacist - Respiratory Medicine, Barts Health NHS Trust
The aim of this session is to discuss the risks and benefits of new
inhaled therapies in respiratory conditions, and support their
evidence-based integration into asthma and COPD management.
Learning outcomes: At the end of this session participants will be
able to:
 Compare the evidence for new drug therapies and contrast to
existing therapies

15.40
16.25
16.25
16.55
17.15
17.30
19.00
Analyse the advantages and disadvantages of new inhaler
devices in order to assess suitability for prescribing for different
patient cohorts
 Justify the cost-effective basis for guideline-based management
of asthma and COPD in future management
d) Working with the Pharmaceutical Industry to improve patient
care (I)
Richard Wysocki MRPharmS, Medical Affairs Director/EU Qualified
Person for Pharmacovigilance, hameln pharmaceuticals ltd,
Gloucester, UK and Dr Clare Crowley, Consultant Pharmacist –
Medicines Safety, Oxford University Hospitals NHS Trust
The aim of this session is to consider how positive patient outcomes
can be delivered through effective interaction between the Pharmacy
Profession and the Pharmaceutical Industry.
Learning outcomes: At the end of this session participants will be
able to:
 Recognise and evaluate opportunities within your own
professional environment for effective engagement with the
Pharmaceutical Industry
 Apply examples of good practice described by your colleagues
to your own professional environment
 Manage barriers and propose solutions to enable effective
interaction with the Pharmaceutical Industry within your own
professional environment
e) What every pharmacist needs to know about skin disease (F)
Dr Christine Clark, Freelance medical writer and pharmaceutical
consultant with special expertise in dermatology, Rossendale,
Lancashire and Dr Gillian Hawksworth, UKCPA Trustee Member and
Senior Lecturer University of Huddersfield, Yorkshire.
The aim of this session is to provide a rapid overview of the
management of the three inflammatory skin diseases and identify
key interventions that improve effective use of medicines in patients
who have eczema, psoriasis or acne.
Learning outcomes: At the end of this session participants will be
able to:
 Describe the prevalence and natural history of eczema, psoriasis
and acne
 State the current first-line treatment recommendations for the
treatment of eczema, psoriasis and acne and be aware of the
guidelines from which they are drawn
 For each disease - eczema, psoriasis and acne - list three key
points that can make treatment more effective
 Explain the implications of chronic skin disease for hospital
inpatients and the importance of effective treatment
Medical Exhibition and refreshments
Medical Exhibition closes
UKCPA Members Presentations, Plenary Suite:
Pharmacy “eight days a week”, Victoria Hill, Lead Pharmacist –
Unscheduled Care, Bradford Teaching Hospitals NHS Foundation Trust
Behavioural insights and nudge theory, Ewan Maule, Deputy Chief
Pharmacist – Operational Services, Northumberland Tyne and Wear
NHS Foundation Trust
UKCPA Clinical Research Grant 2013 Update: Errors in the
Preparation of injectable Medicines in the Pharmacy Environment: A
Failure Modes and Effects Analysis, K Lynette James, Department of
Pharmacy and Pharmacology, University of Bath
Official opening of the Poster Exhibition
First Time Attendees Welcome Meeting (for those unable to attend
the earlier meeting)
Pre Dinner Drinks followed by Symposium Dinner at 19.30
To include the announcement of the UKCPA Lifetime Achievement
Award 2014 winner. Music and dancing to follow.
Saturday 22nd November
08.00
09.00
09.30
Breakfast Meetings
Registration desk opens/poster exhibition viewing
Work session 2 (5 x concurrent sessions)
a) Embedding professionalism, attitudes and values (suitable for
all levels)
Aamer Safdar, UKCPA Education & Training Group and General
Committee Member, and Principal Pharmacist Lead for Education
and Development, Guy's and St Thomas' NHS Foundation Trust and
Abbas Alidina, UKCPA Education & Training Group Committee
Member and Education & Training Pharmacist, Croydon University
Hospital
The aim of this session is to discuss how professionalism, attitudes
and values can be embedded into the workplace and addressing
concerns.
Learning outcomes: At the end of this session participants will be
able to:
 Describe their view of professionalism
 Discuss various methods of dealing with a lack of
professionalism and poor attitude through case studies
 Identify the challenges of embedding professionalism,
attitudes and values into the workplace
11.00
11.30
12.00
12.30
b) Back to basics: Introduction to bacteriology and principles for
use of common antibiotics (F)
Adel Sheikh, UKCPA Pharmacy Infection Network Committee
Member and Lead Pharmacist for Antimicrobials and Respiratory,
Portsmouth Hospitals NHS Trust and David Sharpe, UKCPA
Pharmacy Infection Network Committee Member and Antimicrobial
Pharmacist, Alder Hey Children’s Foundation Trust
The aim of this session is to provide an introduction to basic
bacteriology & the principles for the use of commonly used
antibiotics
Learning outcomes: At the end of this session participants will be
able to:
 Describe the four principal groups of pathogenic bacteria
 Identify the bacteria groups likely to be associated with
different sites of infection
 Outline the spectrum of activity of the major antibiotic classes
 Recommend appropriate antibiotic combinations to cover
common infections
c) VTE- overcoming problems in management in specific patient
groups (II)
Rebecca Chanda, UKCPA Haemostasis, Anticoagulation and
Thrombosis Group Committee Member and Highly Specialist
Pharmacist Anticoagulation, Guy’s and St Thomas’ NHS Foundation
Trust and Katherine Stirling, UKCPA Haemostasis, Anticoagulation
and Thrombosis Group Committee Member and Consultant
Pharmacist Anticoagulation, Leeds Teaching Hospitals NHS Trust
The aim of this session is to discuss the common problems
associated with VTE management in specific patient groups and
discuss strategies for overcoming them.
Learning outcomes: At the end of this session participants will be
able to:
 Discuss the treatment of VTE in the following groups
o IVDU
o Pregnant
o Patients with a VTE while on anticoagulation
o Patients with anti-phospholipid syndrome
o Patients with an IVC filter
d) Recognising and managing sepsis in the non-ITU patient (F)
Snehal Shah, Senior Pharmacist - Critical Care, Royal Brompton and
Harefield NHS Foundation Trust and Fraser Hanks, Highly specialist
pharmacist – Critical Care, Guy’s and St Thomas’ NHS Foundation
Trust
The aim of this session is to provide an insight into the recognition
and management of sepsis in a patient in a non-critical care setting.
Learning outcomes: At the end of this session participants will be
able to:
 Explain the differences between SIRS, sepsis, septic shock
 Describe the incidence and mortality of sepsis
 Discuss the pathophysiology of sepsis
 Discuss the rationale behind the recommendations by the SSC
2013
o Fluid therapy
o Antibiotics
o Inotropes/vasopressors
o Corticosteroids
 Apply these principles to real life patients
e) Quality improvement; which tools and techniques to use in
practice (F)
Kevin Gibbs, UKCPA Medicines Safety and Quality Group Committee
Member and Clinical Pharmacy Manager, University Hospitals
Bristol
The aim of this session is to discuss some tools and measurement
techniques that support quality improvement within the workplace
Learning outcomes: At the end of this session participants will be
able to:
 Explain the principles behind elimination of waste in using
Lean
 Select appropriate tools to use in local quality improvement
initiatives
 Apply the Model for Improvement to any quality improvement
measure
Refreshments and poster exhibition
Keynote Lecture: The future affordability of medicines,
Speaker TBC
UKCPA AGM/Association Update
Poster Viewing Session, plus lunch and refreshments
12.40
13.40
13.50
14.10
14.30
14.45
15.00
Pain Management Satellite Meeting:
 CYP2D6: Its impact on pharmacological pain management,
Drug-Drug Interactions and more, Dr Andrew Dickman,
Consultant Pharmacist, Blackpool Teaching Hospitals NHS
Foundation Trust, supported by Napp Pharmaceuticals Ltd
Poster exhibition closes
UKCPA 2014 Award Acknowledgements including the
announcement of the hameln oral communication and best poster
awards
UKCPA Patient Safety Award 2014 – winner’s presentation
Chair’s Closing Remarks
Refreshments available to take into syndicate rooms
Work session 3 (5 x concurrent sessions)
a) Implications of the Francis Report on pharmacy education and
training (I)
Jill McDonald, joint Chair of the UKCPA Education & Training
Group, Head of School of Pharmacy, Health Education Thames
Valley and Pharmacist Manager – Education & Training, Milton
Keynes Hospital NHS Foundation Trust
The aim of this session is to discuss the main themes highlighted in
the ‘Francis Report’ and how they impact on how we deliver
education and training now and in the future.
Learning outcomes: At the end of this session participants will be
able to:
 List the main themes highlighted in the ‘Francis Report’
 Discuss with your peers the recommendations from the
‘Francis Report’ which link to education and training and
consider how they link to your practice
 Identify examples best practice and learning gaps within
practice based learning and share ideas to support each other
in the workplace
b) Antimicrobial stewardship for the non-specialist (F)
Laura Whitney, UKCPA Pharmacy Infection Network Committee
Member and Consultant Pharmacist – Antimicrobials, St. Georges
Hospital, London and Dr Diane Harris, UKCPA Community Group
Committee Member and Lead Antimicrobial Pharmacist, Southern
Derbyshire CCG
The aim of this session is to provide an overview of antimicrobial
stewardship (AS), its importance in tackling Healthcare Associated
Infection (HAI) and how hospital and community/primary care
pharmacists can contribute.
Learning outcomes: At the end of this session participants will be
able to:
 Explain why antimicrobial resistance and HAI are currently a
priority within healthcare and why effective antimicrobial
stewardship programme is required
 Discuss the role of an antimicrobial pharmacist and how all
pharmacists can contribute to antimicrobial stewardship
within their own area of practice
c) Improving stroke prevention in AF: where are we now? (II)
Frances Akor, Chair of the UKCPA Haemostasis, Anticoagulation
and Thrombosis Group and Consultant Pharmacist,
Anticoagulation, Imperial College Healthcare NHS Trust and
Duncan McRobbie, UKCPA Haemostasis, Anticoagulation and
Thrombosis Group Committee Member and Associate Chief
Pharmacist - Clinical Services, Guy's & St Thomas' NHS Foundation
Trust
The aim of this session is to describe the update to the NICE
recommendations for the management of AF, including treatment
strategies for rate and rhythm control and acute management of
AF anticoagulant management for prevention of stroke.
Learning outcomes: At the end of this session participants will be
able to:
 Provide an overview of the aetiology of atrial fibrillation
 Describe the recommendations by NICE on patients with AF
including:
o Assessment of patients with signs and symptoms of atrial
fibrillation
o Describe the treatment options for controlling heart rate
and rhythm
o Describe the anticoagulant management in patients with
AF to prevent stroke
o Describe the management of acute atrial fibrillation
d) Intensive care sedation from the beginning (I/II)
David Sapsford, UKCPA Critical Care Group and General Committee
Member and Critical Care Pharmacist, West Suffolk Hospital NHS
Foundation Trust
The aim of this session is to critique and rationalise sedation
strategies (both past and present) employed in Intensive Care.
Learning outcomes: At the end of this session participants will be
able to:
 Discuss the goals of sedation in Intensive Care and be able to
describe both desirable and undesirable outcomes following
sedation
 Explain the negative impact of delirium on a patient’s
admission
e) Managing the older surgical patient (II)
Ruth Bosch, Advanced Pharmacist- Surgery and Orthopaedics, Glan
Clwyd Hospital, Betsi Cadwaladr University Health Board and Derek
Taylor, UKCPA Care of the Elderly Group Chair and Assistant
16.30
Director of Pharmacy- Governance and Risk, Royal Liverpool and
Broadgreen University Hospitals NHS Trust
The aim of this session is to discuss the additional medicines
management considerations associated with the older surgical
patient, with particular focus on fractured neck of femur patients.
Learning outcomes: At the end of this session participants will be
able to:
 Discuss the key principles for safe prescribing for older people
during the peri-operative period.
 Describe the usual management pathway for a fractured neck
of femur (#NOF) patient, and identify the key points where
complications may occur
 Apply this knowledge to recommend appropriate symptom
management and thromboprophylaxis regimens for older
patients
 Outline the key evidence and national guidelines for
pharmacological secondary prevention of fractures
Symposium closes
All our symposia work sessions have specific learning outcomes which will enable you to see how your practice will benefit from your attendance. We have also
mapped these learning outcomes to the GLF and Advanced Pharmacy Framework (APF) so that you can easily identify the level that the work session is aimed at, and
the professional development benefits you can achieve. Attending these work sessions will give you the opportunity to apply the knowledge learnt in order to
achieve the competencies outlined in the APF. Don’t forget that you can enter your attendance at work sessions into your CPD or Faculty portfolio.
Key to delivery level for work sessions, based on the GLF and APF:
F = General Level, Foundation
I = Advanced Stage I
Hotel details:
For details about the hotel, location and facilities, please visit:
http://www.ichotelsgroup.com/h/d/cp/1/en/hotel/notws/transportation?start=1
Travel
If you wish to plan your travel route direct, the following websites offer very accurate
guidance: www.rac.co.uk, www.theaa.com, http://maps.google.co.uk/
There is a car park adjacent to the hotel with direct access by lift which has parking for
600 cars.
Satellite and Fringe Meetings
It is anticipated that there will be a number of meetings occurring throughout the
symposium. Further information regarding these meetings will be emailed to
delegates who have reserved a place prior to the symposium.
Oral communication and poster presenters
All authors will be advised if their submission has been accepted and presenters need
to register as delegates.
All oral communication and poster presenters MUST be members of UKCPA.
Posters will be on display in their designated exhibition area from Friday at 15.40 until
13.40 on Saturday afternoon. The poster exhibition will officially open at 17.15 on
Friday. Poster viewing will be available throughout this period but presenters are only
required to stand by their posters to take questions on Saturday. N.B. Oral
communication and poster winners will be announced during the Saturday afternoon
plenary at 14.10.
Social Event
The symposium dinner will take place on the Friday evening. The evening will include
the announcement of the UKCPA Lifetime Achievement Award 2014 winner. A disco
will follow for those wishing to dance into the night.
Symposium dinner dress code
Most delegates wear black tie but lounge suits are perfectly acceptable.
Non healthcare professionals are welcome at this dinner. Guests from the industry
are asked to note this in accordance with the ABPI code of practice.
Exhibition
The Medical Exhibition will take place on Friday 21st November during which lunch
and afternoon refreshments will be served. The UKCPA would like to encourage
delegates to take advantage of the opportunity to visit the stands of exhibiting
companies and organisations.
II = Advanced Stage II
M = Advanced Stage Mastery
Registration Fees
UKCPA members
Non members
2 day symposium including accommodation
and symposium dinner
£350
£430
Twin/double room, fee per delegate
£310
£400
Student rate, 2 days incl accommodation
(limited spaces)
£245
N/A
2 day non residential
(excl accommodation/evening meals)
£270
£370
Student rate, 2 day non residential
(excl accomm/evening meals)
£165
N/A
Day delegate rate Friday
£150
£200
Day delegate rate Saturday
£150
£200
Symposium Dinner#
£ 35
£ 35
(#if not attending as an accommodated symposium delegate)
BPSA, PCPA and APTUK members are eligible to attend this symposium at the UKCPA
members’ rates.
To become a member of the UKCPA, please visit: http://www.ukcpa.net/join
Industry representative registration fees:
2 day symposium incl accommodation
Day delegate rate Friday
Day delegate rate Saturday
2 day non residential
(excl accomm/evening meals)
£350*
£150*
£150*
£640
£395
£395
£270*
£530
*Industry representatives must be part of a UKCPA corporate members package to take
advantage of the members rates.
The UKCPA would encourage all delegates to attend both days to benefit from all
aspects of the symposium and networking opportunities that take place.
Day delegate rates do not include evening meals but do include refreshments and
lunch.
Contact Information:
United Kingdom Clinical Pharmacy Association (UKCPA)
1st Floor, Publicity House, 59 Long Street, Wigston, Leicestershire, LE18 2AJ
Tel: 0116 2889889, Fax: 0116 2889891
Email: [email protected], Website: www.ukcpa.org
To register for this event, please visit: http://www.ukcpa.net/events/conferences/ukcpa-autumn-residential-symposium-2014 and complete the online registration
form.
To enable you to plan your time effectively at the symposium, an ‘at a glance grid’ version of this programme is available here: http://www.ukcpa.net/wpcontent/uploads/2014/06/Autumn-Symposium-at-a-glance-FINAL2.pdf.
The UKCPA, on occasion, secures sponsorship from the pharmaceutical industry to support the financial costs for events that it organises. Industry partners providing
this support are acknowledged on event flyers and programmes (correct at time of print). Symposium sponsorship goes towards supporting venue and audio visual
costs, and various elements of delegate materials (badges, programmes, handouts, delegate lists, etc), UKCPA administration and nominal speaker honorariums and
travel expenses. Sponsorship information can also be obtained by contacting Marie Matthews, UKCPA General Manager, tel: 0116 2889889 or email:
[email protected]. The UKCPA is committed to working with all its industry partners within the ABPI's Code of Practice.